The rest is here: Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
The rest is here: Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
View original post here: TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary...
More here: CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a...
View post: Soleno Therapeutics Strengthens Leadership Team with Key Appointments
Continue reading here: nmible partners with Velocity Clinical Research to streamline clinical trials patient stipends
See the article here: Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
Read more: Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
Follow this link: Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
Read more here: AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for Phase 2 Study of Ampligen® for the Treatment of Locally Advanced...
Read this article: Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine...
Recent Comments